NumerixS Investment Technologies’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,186
| Closed | -$23K | – | 1308 |
|
|
2020
Q1 | $23K | Sell |
2,186
-4,011
| -65% | -$42.2K | 0.01% | 780 |
|
|
2019
Q4 | $102K | Buy |
6,197
+400
| +7% | +$6.58K | 0.02% | 669 |
|
|
2019
Q3 | $77K | Buy |
5,797
+2,598
| +81% | +$34.5K | 0.02% | 626 |
|
|
2019
Q2 | $45K | Sell |
3,199
-9,801
| -75% | -$138K | 0.01% | 791 |
|
|
2019
Q1 | $244K | Buy |
+13,000
| New | +$244K | 0.03% | 598 |
|
|
2018
Q4 | – | Sell |
-2,035
| Closed | -$47K | – | 1398 |
|
|
2018
Q3 | $47K | Sell |
2,035
-9,800
| -83% | -$226K | 0.01% | 986 |
|
|
2018
Q2 | $227K | Buy |
11,835
+5,700
| +93% | +$109K | 0.05% | 485 |
|
|
2018
Q1 | $102K | Sell |
6,135
-1,568
| -20% | -$26.1K | 0.03% | 650 |
|
|
2017
Q4 | $117K | Buy |
7,703
+900
| +13% | +$13.7K | 0.03% | 642 |
|
|
2017
Q3 | $122K | Sell |
6,803
-13,300
| -66% | -$239K | 0.03% | 685 |
|
|
2017
Q2 | $328K | Sell |
20,103
-20,400
| -50% | -$333K | 0.05% | 464 |
|
|
2017
Q1 | $567K | Buy |
40,503
+25,800
| +175% | +$361K | 0.07% | 368 |
|
|
2016
Q4 | $235K | Sell |
14,703
-4,997
| -25% | -$79.9K | 0.03% | 626 |
|
|
2016
Q3 | $328K | Buy |
19,700
+13,500
| +218% | +$225K | 0.04% | 518 |
|
|
2016
Q2 | $69K | Buy |
+6,200
| New | +$69K | 0.01% | 921 |
|